Welcome to LookChem.com Sign In|Join Free
  • or
1-(3,4-dihydro-2H-chromen-4-yl)-4-methylpiperazine is a complex chemical compound that is a derivative of piperazine with a chromenyl group attached and a methyl substitution at the piperazine nitrogen. 1-(3,4-dihydro-2H-chromen-4-yl)-4-methylpiperazine features a six-membered ring fused to a benzene ring in the chromenyl group and a six-membered ring with two nitrogen atoms in the piperazine group. Its unique molecular structure suggests potential pharmacological and biological activities, particularly interactions with serotonin receptors, making it a promising candidate for applications in medicinal chemistry and drug development.

81816-67-3

Post Buying Request

81816-67-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

81816-67-3 Usage

Uses

Used in Pharmaceutical Industry:
1-(3,4-dihydro-2H-chromen-4-yl)-4-methylpiperazine is used as a pharmacological agent for its potential interactions with serotonin receptors. Its unique structure allows it to be a candidate for the development of new drugs targeting serotonin-related disorders, which could have a significant impact on the treatment of various conditions such as depression, anxiety, and other mood disorders.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(3,4-dihydro-2H-chromen-4-yl)-4-methylpiperazine is used as a chemical probe to study the interactions between molecules and serotonin receptors. This research can lead to a better understanding of the underlying mechanisms of serotonin-related diseases and contribute to the design and development of more effective therapeutic agents.
Used in Drug Development:
1-(3,4-dihydro-2H-chromen-4-yl)-4-methylpiperazine is utilized as a lead compound in the drug development process. Its potential pharmacological activities and unique structure make it a valuable starting point for the synthesis of new drugs with improved efficacy and selectivity for serotonin receptors, potentially leading to more effective treatments for a range of conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 81816-67-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,8,1 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 81816-67:
(7*8)+(6*1)+(5*8)+(4*1)+(3*6)+(2*6)+(1*7)=143
143 % 10 = 3
So 81816-67-3 is a valid CAS Registry Number.

81816-67-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3,4-dihydro-2H-chromen-4-yl)-4-methylpiperazine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:81816-67-3 SDS

81816-67-3Downstream Products

81816-67-3Relevant academic research and scientific papers

AMINO SUBSTITUTED BENZO(HETERO)CYCLIC DERIVATIVES

-

Page 21, (2010/02/08)

Use of compounds Formula (I), A = a 5- to 7-membered ring which may contain 1-3 heteroatoms and which may be saturated or partially or completely unsaturated; R= OH, SH, NH2, CN, NO2, halogen, C1-C6-alkyl, C1-C6-haloalkyl; C1-C6- alkoxy, C1-C6-haloalko

Phenoxyalkylamines in Semi-rigid Conformation: Synthesis & Pharmacological Activity of N1-(4'-Chromanyl)-N4-arylpiperazines & N1-(2'-Chromanylmethyl)-N4-arylpiperazines

Pratap, Ram,Gupta, R. C.,Anand, Nitya

, p. 1063 - 1067 (2007/10/02)

Synthesis and pharmacological activity of N1-(4'-chromanyl)-N4-arylpiperazines and N1-(chromanylmethyl)-N4-arylpiperazines, cyclic congeners of N1-aryloxyalkyl-N4-arylpiperazines, are reported.None of the compounds of this series shows any significant pharmacological activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 81816-67-3